In liver cancer, protein–protein interface analysis proved CRKL as a unique marker for HCC, and analysis of the differential network biology resolved the innovative communication between CRKL-FLT1 which intensely correlated with the migrating capacity of HCC (Liu et al., 2013a,b). The gene discussed is FLT1; the disease is liver cancer.